ACTRN12621001415897
Not yet recruiting
未知
The effects of Gender Affirming hormone therapy on skeletal Muscle training and Epigenetics in transgender individuals: The GAME Study
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- muscle health and performance
- Sponsor
- Victoria University
- Enrollment
- 160
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •For participants commencing gender affirming hormone therapy:
- •Adults aged 18 years and over.
- •Willingness to consent and comply with study requirements
- •Diagnosed with gender dysphoria who are about to commence gender affirming hormone therapy
- •For matched cisgender participants:
- •Adults aged 18 years and over.
- •Willingness to consent and comply with study requirements
- •Age\-matched to participating individual about to commence gender affirming hormone therapy
Exclusion Criteria
- •Prior use of gender affirming hormone therapy.
- •Prior hypogonadism including previous oophorectomy or orchidectomy.
- •Past medical history of cardiovascular conditions, dizziness or fainting during exertion, significant chronic or recurrent respiratory condition, significant neuromuscular, major musculoskeletal problems interfering with ability to cycle, uncontrolled endocrine and metabolic disorders or diabetes requiring insulin and other therapies, infectious blood borne disease, disorders or use of medications that will affect blood clotting and allergies to anaesthetic.
- •Active cigarette use.
- •Language difficulties.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Effect of hormonal therapy versus no treatment on testicular histopathology and fertility in patients with non-obstructive azoospermianon-obstructive azoospermia.Male infertilityIRCT201612069014N137Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences28
Active, not recruiting
Phase 1
Impact of new generation hormono-therapy on cognitive functions in elderly patients treated for a metastatic prostate cancerMetastatic prostate cancerTherapeutic area: Diseases [C] - Cancer [C04]EUCTR2016-001248-20-FRCentre François Baclesse222
Recruiting
Phase 2
Effect of changes in Gonadotropin Realizing Hormone (GnRH) injection time on intrauterine insemination in infertile womeFemale infertility.Female infertilityIRCT20120215009014N287Hamedan University of Medical Sciences316
Completed
Phase 4
Ganirelix in insemination cycles of women with premature luteinizatioinfertilityintrauterine inseminationReproductive Health and Childbirth - Fertility including in vitro fertilisationACTRN12612000153819Mersin University114
Completed
Not Applicable
Effects of Gender-affirming Hormone Therapy on Transgender PeopleGender DysphoriaNCT06022562National Taiwan University227